Madrigal Pharmaceuticals Inc MDGL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:19 PM EDT
233.43quote price arrow up+17.38 (+8.04%)
Volume
240,750
52 week range
119.76 - 313.11
Loading...
  • Open223.35
  • Day High233.45
  • Day Low221.25
  • Prev Close216.05
  • 52 Week High313.11
  • 52 Week High Date05/08/23
  • 52 Week Low119.76
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap4.968B
  • Shares Out21.28M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta-0.44
  • YTD % Change0.32

KEY STATS

  • Open223.35
  • Day High233.45
  • Day Low221.25
  • Prev Close216.05
  • 52 Week High313.11
  • 52 Week High Date05/08/23
  • 52 Week Low119.76
  • 52 Week Low Date10/27/23
  • Market Cap4.968B
  • Shares Out21.28M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta-0.44
  • YTD % Change0.32

RATIOS/PROFITABILITY

  • EPS (TTM)-19.93
  • P/E (TTM)-11.71
  • Fwd P/E (NTM)-9.63
  • EBITDA (TTM)-379.969M
  • ROE (TTM)-123.98%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)28.49%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Madrigal Pharmaceuticals Inc

 

Profile

MORE
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes...
Julian Baker
Independent Chairman of the Board
Bill Sibold
President, Chief Executive Officer, Director
Mardi Dier
Chief Financial Officer, Senior Vice President
Ronald Filippo
Chief Information Officer
Address
200 Barr Harbor Dr Ste 400
West Conshohocken, PA
19428-2978
United States

Top Peers

SYMBOLLASTCHG%CHG
NUVL
Nuvalent Inc
70.97-1.52-2.09%
BBIO
BridgeBio Pharma Inc
27.50-0.24-0.87%
KRYS
Krystal Biotech Inc
160.12-0.10-0.07%
ALPN
Alpine Immune Sciences Inc
64.58-0.02-0.02%
BHVN
Biohaven Ltd
40.79+0.89+2.22%